1.97
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt FBIO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.89
Offen:
$1.88
24-Stunden-Volumen:
214.35K
Relative Volume:
1.06
Marktkapitalisierung:
$58.25M
Einnahmen:
$80.97M
Nettoeinkommen (Verlust:
$-78.31M
KGV:
-0.1777
EPS:
-11.0849
Netto-Cashflow:
$-129.56M
1W Leistung:
+1.55%
1M Leistung:
+10.67%
6M Leistung:
+8.84%
1J Leistung:
-16.53%
Fortress Biotech Inc Stock (FBIO) Company Profile
Firmenname
Fortress Biotech Inc
Sektor
Branche
Telefon
781-652-4500
Adresse
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Vergleichen Sie FBIO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
FBIO
Fortress Biotech Inc
|
1.97 | 57.37M | 80.97M | -78.31M | -129.56M | -11.08 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-03-15 | Fortgesetzt | ROTH MKM | Buy |
2022-08-04 | Eingeleitet | Ladenburg Thalmann | Buy |
2020-10-02 | Eingeleitet | The Benchmark Company | Buy |
2019-12-18 | Eingeleitet | B. Riley FBR | Buy |
2018-02-28 | Eingeleitet | B. Riley FBR, Inc. | Buy |
2017-07-11 | Eingeleitet | Rodman & Renshaw | Buy |
2017-03-22 | Eingeleitet | JMP Securities | Mkt Outperform |
2016-10-03 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Fortress Biotech Inc Aktie (FBIO) Neueste Nachrichten
What drives Fortress Biotech Inc. stock priceSuperior portfolio returns - Autocar Professional
Fortress Biotech Inc. Stock Analysis and ForecastFree Wealth Planning Blueprint - jammulinksnews.com
What analysts say about Fortress Biotech Inc. stockExceptional market performance - jammulinksnews.com
How Fortress Biotech Inc. stock performs during market volatilityCapital Growth Picks - Newser
Will Fortress Biotech Inc. stock split in the near futureVerified Return Tips - beatles.ru
Is Fortress Biotech Inc. a good long term investmentExponentially increasing returns - jammulinksnews.com
AstraZeneca’s Anselamimab Trial Shows Mixed Results - TipRanks
Why Fortress Biotech Inc. stock attracts strong analyst attentionFree AI-Powered Stock Predictions - Newser
What makes Fortress Biotech Inc. stock price move sharplyMarket Ready Callouts - Newser
why fortress biotech inc. stock attracts strong analyst attentionProfessional Stock Screener - Newser
Why Fast-paced Mover Fortress Biotech (FBIO) Is a Great Choice for Value Investors - Yahoo Finance
Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™ - Stock Titan
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for - GlobeNewswire
(FBIOP) Trading Advice - news.stocktradersdaily.com
Fortress Biotech, Inc.(NasdaqCM: FBIO) dropped from Russell 3000E Growth Index - MarketScreener
(FBIOP) Investment Analysis and Advice - news.stocktradersdaily.com
Journey Medical to Join Russell 2000® and Russell 3000® Indexes - GlobeNewswire
Fortress Biotech shareholders approve board proposals at annual meeting - Investing.com
Journey Medical Corporation Announces Emrosi™ Data Analysis - GlobeNewswire
Despite Fast-paced Momentum, Fortress Biotech (FBIO) Is Still a Bargain Stock - Nasdaq
How To Trade (FBIOP) - news.stocktradersdaily.com
Two Sigma Investments LP Invests $109,000 in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV - GlobeNewswire
Jane Street Group LLC Takes Position in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fortress Biotech, Inc. of Class Action Lawsuit and Upcoming Deadline – FBIO - ACCESS Newswire
Fortress Biotech (FBIO) Is Attractively Priced Despite Fast-paced Momentum - Yahoo Finance
Checkpoint Therapeutics, Inc.(NasdaqCM: CKPT) dropped from S&P TMI Index - marketscreener.com
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpo - GuruFocus
Fortress Biotech Announces Sale of Subsidiary Checkpoint Therapeutics - citybiz
Sun Pharmaceutical Industries Completes Acquisition Of Checkpoint Therapeutics - marketscreener.com
Fortress Biotech Closes Sale of Checkpoint Therapeutics Unit - marketscreener.com
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics | FBIO Stock News - GuruFocus
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - GlobeNewswire
Fortress Biotech, Inc. Announces Acquisition of Checkpoint Therapeutics by Sun Pharmaceutical Industries Limited - Nasdaq
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - Benzinga
Fortress Biotech: Forging a Fortress Through Strategic Asset Realization and Portfolio Precision - AInvest
Checkpoint Therapeutics shareholders approve Sun Pharma merger By Investing.com - Investing.com India
One Fortress Biotech Insider Raised Stake By 26% In Previous Year - simplywall.st
Checkpoint Investor Sues for Info on Sale From Fortress to Sun - Bloomberg Law News
Checkpoint Pharma Sued Over Controversial $355M Merger - USA Herald
New Strong Sell Stocks for May 16th - The Globe and Mail
Finanzdaten der Fortress Biotech Inc-Aktie (FBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):